View the BIG 100 largest medical device companies in the world listings hereDexcom2022 Rank: 452021 Rank: 49HeadquartersSan DiegoUnited Stateshttps://www.dexcom.com 2022 Revenues ($USD) : $2,448,500,0002022 R&D spend : $517,100,0002022 Number of Employees : 6,300Fiscal Year End : 12/31/2021Company CEO : Kevin Sayer, chair, president and CEOThe San Diego–based developer of continuous glucose monitoring (CGM) technology sat poised for a big 2022. CEO Kevin Sayer claimed at the start of the year that he planned for “more activity” than the company had ever seen, with the expected FDA clearance and launch for the next-generation Dexcom G7 CGM. The company suffered a setback after having to make software tweaks to G7 on guidance from the FDA, pushing back the G7 timeline. Still, Dexcom moved forward with the launch of its differentiated Dexcom One offering, FDA breakthrough device designation for the use of its CGMs in hospitals, and more. –SW Previous: HU Group ( #44 ) Next: Dräger (medical division) ( #46 )